Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Pediatric Patients With Relapsing Multiple Sclerosis (FOCUS)

No therapies have been formally approved by the Food and Drug Administration for use in pediatric multiple sclerosis, a rare disease.

Gespeichert in:
Autor*in:

Alroughani, Raed [verfasserIn]

Das, Rajiv

Penner, Natasha

Pultz, Joe

Taylor, Catherine

Eraly, Satish

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2018

Umfang:

6

Übergeordnetes Werk:

Enthalten in: NOVEL INSIGHTS INTO THE PHYSIOLOGY OF CARDIAC-CORONARY INTERACTION: A FIRST-IN-HUMAN STUDY UTILISING INVASIVE REAL-TIME SIMULTANEOUS MEASURES OF CORONARY AND LEFT VENTRICULAR HEMODYNAMICS - Patterson, Tiffany ELSEVIER, 2016, Amsterdam [u.a.]

Übergeordnetes Werk:

volume:83 ; year:2018 ; pages:19-24 ; extent:6

Links:

Volltext

DOI / URN:

10.1016/j.pediatrneurol.2018.03.007

Katalog-ID:

ELV043304257

Nicht das Richtige dabei?

Schreiben Sie uns!